Northern Trust Corp Tarsus Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 253,016 shares of TARS stock, worth $8.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,016

Previous 247,177 2.36%

Holding current value

$8.39 Million

Previous $8.98 Million 23.46%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.17 - $38.73 $146,967 - $226,144	5,839 Added 2.36%	253,016 $6.88 Million
Q1 2024 May 14, 2024	SELL	$19.61 - $39.22 $30,846 - $61,693	-1,573 Reduced 0.63%	247,177 $8.98 Million
Q4 2023 Feb 13, 2024	BUY	$12.98 - $20.73 $486,230 - $776,545	37,460 Added 17.73%	248,750 $5.04 Million
Q3 2023 Nov 13, 2023	BUY	$14.75 - $24.62 $265,603 - $443,332	18,007 Added 9.32%	211,290 $3.75 Million
Q2 2023 Aug 11, 2023	BUY	$11.57 - $19.63 $484,979 - $822,830	41,917 Added 27.69%	193,283 $3.49 Million
Q1 2023 May 15, 2023	SELL	$11.92 - $16.27 $37,536 - $51,234	-3,149 Reduced 2.04%	151,366 $1.9 Million
Q4 2022 Feb 13, 2023	BUY	$14.12 - $18.72 $66,815 - $88,583	4,732 Added 3.16%	154,515 $2.27 Million
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $149,754 - $196,766	10,636 Added 7.64%	149,783 $2.56 Million
Q2 2022 Aug 12, 2022	BUY	$11.08 - $19.08 $780,198 - $1.34 Million	70,415 Added 102.45%	139,147 $2.03 Million
Q1 2022 May 13, 2022	SELL	$14.49 - $24.28 $44,180 - $74,029	-3,049 Reduced 4.25%	68,732 $1.16 Million
Q4 2021 Feb 08, 2022	SELL	$21.21 - $29.68 $47,298 - $66,186	-2,230 Reduced 3.01%	71,781 $1.62 Million
Q3 2021 Nov 15, 2021	SELL	$21.45 - $29.22 $120,634 - $164,333	-5,624 Reduced 7.06%	74,011 $1.6 Million
Q2 2021 Aug 13, 2021	BUY	$27.16 - $38.59 $342,216 - $486,234	12,600 Added 18.8%	79,635 $2.31 Million
Q1 2021 May 12, 2021	SELL	$27.37 - $47.25 $92,072 - $158,949	-3,364 Reduced 4.78%	67,035 $2.16 Million
Q4 2020 Feb 11, 2021	BUY	$19.17 - $49.62 $1.35 Million - $3.49 Million	70,399 New	70,399 $2.91 Million

Others Institutions Holding TARS

# of Institutions

155

Shares Held

40.4M

Call Options Held

37.9K

Put Options Held

808K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $884M
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Tarsus Pharmaceuticals, Inc. Transaction History